Dr Reddy’s shares fell after Goldman Sachs and Citigroup turned cautious, citing limited growth visibility, pipeline concerns and valuation risks. Brokerages flagged lower earnings potential amid generics pricing pressure and muted opportunities in semaglutide. Despite earlier optimism, analysts see downside risks persisting in the near term.Read More
Japan’s core inflation slipped below the Bank of Japan’s 2% target for a second straight month in March, as subsidies and easing food prices offset energy pressures. While underlying inflation remains resilient, rising oil costs and geopolitical risks may push prices higher, keeping policymakers cautious on future interest rate decisions.Read More
Union Bank of India shares fell sharply after its Q4FY26 results disappointed brokerages despite a rise in net profit. Weak NII, a sharp spike in provisions and margin pressure weighed on sentiment. While asset quality improved, analysts remain cautious, citing elevated credit costs and limited upside in the near term.Read More
HCL Tech shares have plunged sharply after weak Q4 earnings and subdued FY27 guidance, triggering multiple broker downgrades and target cuts. Concerns over slowing growth, reduced discretionary spending, and limited visibility on recovery have weighed on sentiment, with analysts expecting continued pressure on the stock in the near term.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
